Immune Modulation Research
Compounds studied for innate immune signaling, T-cell regulation, antiviral defense, and immune system homeostasis
Immune modulation research examines the biological mechanisms by which compounds influence the activation, differentiation, and regulation of immune cell populations. The immune system operates across innate and adaptive axes, with dendritic cells, macrophages, natural killer cells, and T-cell subsets all representing research targets in this area. Compounds in this use case are studied for their ability to influence Toll-like receptor signaling, cytokine balance, antiviral defense, T-cell maturation, and regulatory immune pathways. Both direct immune modulators and compounds with indirect immune-relevant properties are included here, reflecting the multi-layered nature of immune system research.
Compounds in This Use Case
Each compound contributes a distinct mechanism relevant to this research objective.
Thymosin Alpha-1
$99Role
Primary thymic immune modulator studied for TLR activation, dendritic cell maturation, and T-cell differentiation in innate and adaptive immune research.
Mechanism
Activates TLR2 and TLR9 on dendritic cells and macrophages, promotes innate immune signaling and antigen-presenting cell maturation, and modulates cytotoxic T-cell and regulatory T-cell activity, with human clinical data in hepatitis and cancer immunotherapy contexts.
BPC-157
$119Role
Cytoprotective peptide with documented anti-inflammatory properties relevant to immune-adjacent tissue injury models.
Mechanism
Modulates nitric oxide signaling and reduces pro-inflammatory cytokine activity in tissue injury models, providing immune-relevant cytoprotection across gut, CNS, and connective tissue research contexts.
NAD+
$279Role
Coenzyme studied for immune cell energy metabolism, sirtuin-mediated immune gene regulation, and PARP-dependent DNA repair in immune cell populations.
Mechanism
Supports sirtuin activity (particularly SIRT1) in immune cells, regulating inflammatory gene expression and cytokine production, while PARP activation enables DNA repair in rapidly dividing immune cell populations.
Epithalon
$199Role
Tetrapeptide studied for immune cell aging effects and NK cell activity in animal models, with relevance to immune senescence research.
Mechanism
Activates telomerase in somatic cells including immune cell populations, with documented effects on NK cell activity and immune cell aging in animal studies, positioning it as a compound of interest in immune senescence research.
Research Context
Thymosin Alpha-1 has the most established clinical research profile of any compound in this use case, with human trial data from chronic hepatitis B and C studies, cancer immunotherapy adjunct research, and sepsis-related immune dysfunction investigations. Its regulatory approval in multiple countries for hepatitis B treatment makes it one of the most clinically validated peptides in the Spartan catalog. BPC-157, NAD+, and Epithalon contribute immune-adjacent mechanisms that researchers include in multi-compound immune models.
Related Compound Comparisons
Explore side-by-side mechanism comparisons for the compounds in this use case.
Frequently Asked Questions
Source These Compounds
All compounds in this use case are available from Spartan Peptides at least 98% HPLC-verified purity. Domestic US supply with same-day dispatch before 2 PM. For in-vitro research use only.
All compounds are strictly for in-vitro research use only and not intended for human consumption.